245 related articles for article (PubMed ID: 35980030)
1. Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies.
Molina MA; Coenen BA; Leenders WPJ; Andralojc KM; Huynen MA; Melchers WJG
mBio; 2022 Oct; 13(5):e0161922. PubMed ID: 35980030
[TBL] [Abstract][Full Text] [Related]
2. Novel high-resolution targeted sequencing of the cervicovaginal microbiome.
Andralojc KM; Molina MA; Qiu M; Spruijtenburg B; Rasing M; Pater B; Huynen MA; Dutilh BE; Ederveen THA; Elmelik D; Siebers AG; Loopik D; Bekkers RLM; Leenders WPJ; Melchers WJG
BMC Biol; 2021 Dec; 19(1):267. PubMed ID: 34915863
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection.
Molina MA; Melchers WJG; Andralojc KM; Leenders WPJ; Huynen MA
Comput Struct Biotechnol J; 2023; 21():4424-4431. PubMed ID: 37731597
[TBL] [Abstract][Full Text] [Related]
4. In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling.
Molina MA; Andralojc KM; Huynen MA; Leenders WPJ; Melchers WJG
NPJ Biofilms Microbiomes; 2022 Sep; 8(1):75. PubMed ID: 36171433
[TBL] [Abstract][Full Text] [Related]
5. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
[TBL] [Abstract][Full Text] [Related]
6. Changes in the cervicovaginal microbiota composition of HPV16-infected patients after clinical treatment.
Li C; Zhang Z; Yang Y; Liao H
Cancer Med; 2022 Dec; 11(24):5037-5049. PubMed ID: 35569127
[TBL] [Abstract][Full Text] [Related]
7. Changes in the Cervical Microbiota of Women with Different High-Risk Human Papillomavirus Loads.
Camargo M; Vega L; Muñoz M; Sánchez R; Patarroyo ME; Ramírez JD; Patarroyo MA
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560678
[TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
Kaelin EA; Skidmore PT; Łaniewski P; Holland LA; Chase DM; Herbst-Kralovetz MM; Lim ES
mSystems; 2022 Apr; 7(2):e0006422. PubMed ID: 35343798
[TBL] [Abstract][Full Text] [Related]
9. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
10. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
Tosado-Rodríguez E; Mendez LB; Espino AM; Dorta-Estremera S; Aquino EE; Romaguera J; Godoy-Vitorino F
PLoS One; 2023; 18(12):e0284673. PubMed ID: 38064478
[TBL] [Abstract][Full Text] [Related]
11. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types.
Huang X; Li C; Li F; Zhao J; Wan X; Wang K
Int J Cancer; 2018 Aug; 143(3):621-634. PubMed ID: 29479697
[TBL] [Abstract][Full Text] [Related]
12. Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women.
Dareng EO; Ma B; Adebamowo SN; Famooto A; Ravel J; Pharoah PP; Adebamowo CA
Sci Rep; 2020 Nov; 10(1):19095. PubMed ID: 33154533
[TBL] [Abstract][Full Text] [Related]
13. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
[TBL] [Abstract][Full Text] [Related]
14. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.
Dareng EO; Ma B; Famooto AO; Adebamowo SN; Offiong RA; Olaniyan O; Dakum PS; Wheeler CM; Fadrosh D; Yang H; Gajer P; Brotman RM; Ravel J; Adebamowo CA
Epidemiol Infect; 2016 Jan; 144(1):123-37. PubMed ID: 26062721
[TBL] [Abstract][Full Text] [Related]
15. Cervicovaginal loads of
Belleti R; Marcolino LD; Novak J; Ferreira CST; do Nascimento Bolpetti A; da Silva Pinto GV; de Oliveira AP; da Silva MG; Marconi C
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35580018
[No Abstract] [Full Text] [Related]
16. Cervicovaginal Microbiome after Cervical Intraepithelial Neoplasia Treatment. A Protocol for Systematic Review and Meta-Analysis.
Janicka-Kośnik M; Sarecka-Hujar B; Jakiel G; Słabuszewska-Jóźwiak A
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501639
[TBL] [Abstract][Full Text] [Related]
17. Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China.
Zhang Z; Li T; Zhang D; Zong X; Bai H; Bi H; Liu Z
BMC Microbiol; 2021 Mar; 21(1):90. PubMed ID: 33765914
[TBL] [Abstract][Full Text] [Related]
18. A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis.
Bik EM; Bird SW; Bustamante JP; Leon LE; Nieto PA; Addae K; Alegría-Mera V; Bravo C; Bravo D; Cardenas JP; Carson GA; Caughey A; Covarrubias PC; Pérez-Donoso J; Gass G; Gupta SL; Harman K; Hongo DMB; Jiménez JC; Kraal L; Melis-Arcos F; Morales EH; Morton A; Navas CF; Nuñez H; Olivares E; Órdenes-Aenishanslins N; Ossandon FJ; Phan R; Pino R; Soto-Liebe K; Varas I; Vera-Wolf P; Walton NA; Almonacid DE; Goddard AD; Ugalde JA; Zneimer S; Richman J; Apte ZS
PLoS One; 2019; 14(5):e0215945. PubMed ID: 31042762
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection.
Dai W; Du H; Li S; Wu R
Front Oncol; 2021; 11():722639. PubMed ID: 34395294
[TBL] [Abstract][Full Text] [Related]
20. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
